Applied Genetic Technologies Corporation (NASDAQ:AGTC) is trading up in the pre-market session on Wednesday.
As of 7:40, LQDA stock is moving higher by 1% to $4.01. So far more than 7.90K have exchanged hands.
AGTC Expands Leadership Team with Appointment of Key Regulatory Leader
- announced the appointment of Janet C. Rae, RAC, as Senior Vice President of Global Regulatory and Quality. The appointment of Ms. Rae, who will join AGTC on June 18, 2021, is an important step in the Company’s strategy to prepare for anticipated late-stage development of its X-Linked Retinitis Pigmentosa (XLRP) and Achromatopsia (ACHM) programs.
- She will be instrumental in assuring regulatory compliance as the Company initiates its previously announced plans to lease a build-to-suit 21,000 square foot current Good Manufacturing Practices (cGMP) manufacturing and quality control facility adjacent to its Florida facility.
- Ms. Rae brings nearly 30 years of experience in the regulatory affairs industry across drug, biologic and gene therapy products with a specialization in orphan drugs and rare disease therapy development.
“We are thrilled to welcome Janet as another high-caliber member of AGTC’s management team and expect that her extensive expertise will enable her to lead our global regulatory and quality groups and develop our long-term strategy effectively. Janet’s arrival comes at an extremely exciting time for AGTC as we just announced positive data from our ongoing Phase 1/2 XLRP clinical trial and planned expansion of our manufacturing and analytics capabilities,” said Sue Washer, President and CEO of AGTC.